Jack W Jack W. Schuler Livi... Net Worth

The estimated Net Worth of Jack W Jack W. Schuler Livi... is at least 512 千$ dollars as of 29 December 2016. Jack Livi owns over 43,557 units of Biolase Inc stock worth over 511,938$ and over the last 9 years Jack sold BIOL stock worth over 0$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jack Livi BIOL stock SEC Form 4 insiders trading

Jack has made over 22 trades of the Biolase Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Jack bought 43,557 units of BIOL stock worth 64,464$ on 29 December 2016.

The largest trade Jack's ever made was buying 229,271 units of Biolase Inc stock on 24 November 2015 worth over 183,417$. On average, Jack trades about 32,577 units every 15 days since 2015. As of 29 December 2016 Jack still owns at least 10,238,756 units of Biolase Inc stock.

You can see the complete history of Jack Livi stock trades at the bottom of the page.

Insiders trading at Biolase Inc

Over the last 12 years, insiders at Biolase Inc have traded over 9,258,543$ worth of Biolase Inc stock and bought 25,366,011 units worth 28,515,794$ . The most active insiders traders include Jack W Schuler、Larry Noracle Partners Lp O...、Larry N Feinberg. On average, Biolase Inc executives and independent directors trade stock every 57 days with the average trade being worth of 31,910$. The most recent stock trade was executed by Jonathan T Md Lord on 7 December 2022, trading 3,537 units of BIOL stock currently worth 2,653$.

What does Biolase Inc do?

biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. biolase’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. biolase is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Complete history of Jack Livi stock trades at Biolase Inc

Biolase Inc executives and stock owners

Biolase Inc executives and other stock owners filed with the SEC include:

• Todd Norbe,
  President, Chief Executive Officer, Director
• John Beaver,
  Chief Financial Officer, Executive Vice President
• John R. Beaver,
  Pres, CEO & Director
• Jonathan Lord,
  Independent Chairman of the Board
• Michael Polyviou,
  IR Contact Officer
• Elaine Wagner,
  Independent Director
• Garrett Sato,
  Independent Director
• Jess Roper,
  Independent Director
• Richard Lanman,
  Independent Director
• Michael DiTolla,
  Independent Director
• Richard Whipp,
  Vice President - Operations
• Richard R. Whipp,
  VP of Operations
• Jennifer Bright,
  VP of Fin.
• David Rodriguez,
  Director of Education & Events
• Brendan O'Connell,
  VP of Fin. and Corp. Controller
• Michael C. Carroll,
  Corp. Sec.
• Holger Arens,
  VP & MD of Europe, the Middle East & Africa
• Dr. Samuel B. Low,
  Chief Dental Officer and VP of Dental & Clinical Affairs
• Matthew Wilson,
  VP of HR
• Daniel Merkin,
  National Sales Director
• Larry Noracle Partners Lp O...,
  
• David C Dreyer,
  SVP / Chief Financial Officer
• Jack W Jack W. Schuler Livi...,
  
• Mark Joseph Nelson,
  SVP & Chief Financial Officer
• Paul N Clark,
  Director
• James R Talevich,
  Director
• Frederic H Moll,
  Director
• Harold C Jr. Flynn,
  President and CEO
• Jack W Schuler,
  
• Larry Noracle Partners Lp O...,
  
• Carol Gomez Dds Summerhays,
  Director
• Martha J. Dds, Ph D Somerman,
  Director
• Larry Noracle Partners Lp F...,
  
• Larry N Feinberg,
  10% owner
• Frederick D. Furry,
  Chief Financial Officer
• Jeffrey M Nugent,
  Acting Chief Executive Officer
• Samuel Bernard Low,
  Director
• Erin S. Enright,
  Director
• Alexander K. Arrow,
  President and COO
• Norman J. Nemoy,
  Director
• Gregory Lichtwardt,
  Director
• Federico Pignatelli,
  Chairman and CEO
• Kenneth P. Yale,
  Director
• Kathleen T O Loughlin,
  Director
• Steven Sandor,
  Chief Operating Officer
• Jennifer Bright,
  Chief Financial Officer
• Education Foundation Schuler,